TY - JOUR
T1 - CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls
AU - Moreno, Francisco A.
AU - Parkinson, Damian
AU - Palmer, Craig
AU - Castro, Wm Lesley
AU - Misiaszek, John
AU - El Khoury, Aram
AU - Mathé, Aleksander A.
AU - Wright, Ron
AU - Delgado, Pedro L.
N1 - Funding Information:
This study was supported by The National Institute of Mental Health RO3 MH57364-01A1 in funding the study portion that included the medication-free subjects and healthy control groups.The University of Arizona Health Sciences Center Dean's Physician Scientist Career Development Award to Dr. Moreno assisted the study portion that included the paroxetine treatment group.The Arizona Hispanic Center of Excellence provided the logistic support.The Swedish Medical Research Council grant 10414 supported the efforts of Dr. A. Mathé.
Funding Information:
This study was supported by The National Institute of Mental Health ( RO3 MH57364-01A1 ), the Arizona Hispanic Center of Excellence , and the University of Arizona Health Sciences Center Dean's Physician Scientist Career Development Award to Dr. Moreno.
Funding Information:
This study was also supported by the Swedish Medical Research Council grant 10414 to Dr. Mathé.
PY - 2010/1
Y1 - 2010/1
N2 - The purpose of this study was to examine the differential effects of acute tryptophan (TRP) depletion vs. sham condition on plasma, cerebrospinal fluid (CSF) biochemical parameters, and mood in the following three subject groups: (1) nine antidepressant-free individuals with remitted depression, (2) eight paroxetine-treated individuals with recently remitted depression, and (3) seven healthy controls. Plasma TRP decreased during TRP depletion and increased during sham condition (p < .01). CSF TRP and 5-hydroxyindoleacetic acid were lower during TRP depletion than sham condition (p < .01 each). During TRP depletion, CSF TRP correlated significantly with the plasma sum of large neutral amino acids (ΣLNAA) (R = -.52, p = .01), but did not significantly correlate with plasma TRP (R = .15, p = .52). The correlation between CSF TRP and ratio of TRP to ΣLNAA was R = .41 and p = .06 during TRP depletion, and R = -.44 and p = .04 during sham condition. A negative correlation trend was observed between CSF-TRP levels and peak Hamilton Depression Rating Scale scores during TRP depletion in patients recovered from depression (R = -.45, p = .07), but not in healthy controls (R = -.01, p = .98). CSF neuropeptide Y was higher during TRP depletion than sham condition (t = 1.75, p < .10). These results illustrate the importance of assessing plasma ΣLNAA when using the TRP depletion paradigm. The use of a single CSF sampling technique although practical may result in data acquisition limitations.
AB - The purpose of this study was to examine the differential effects of acute tryptophan (TRP) depletion vs. sham condition on plasma, cerebrospinal fluid (CSF) biochemical parameters, and mood in the following three subject groups: (1) nine antidepressant-free individuals with remitted depression, (2) eight paroxetine-treated individuals with recently remitted depression, and (3) seven healthy controls. Plasma TRP decreased during TRP depletion and increased during sham condition (p < .01). CSF TRP and 5-hydroxyindoleacetic acid were lower during TRP depletion than sham condition (p < .01 each). During TRP depletion, CSF TRP correlated significantly with the plasma sum of large neutral amino acids (ΣLNAA) (R = -.52, p = .01), but did not significantly correlate with plasma TRP (R = .15, p = .52). The correlation between CSF TRP and ratio of TRP to ΣLNAA was R = .41 and p = .06 during TRP depletion, and R = -.44 and p = .04 during sham condition. A negative correlation trend was observed between CSF-TRP levels and peak Hamilton Depression Rating Scale scores during TRP depletion in patients recovered from depression (R = -.45, p = .07), but not in healthy controls (R = -.01, p = .98). CSF neuropeptide Y was higher during TRP depletion than sham condition (t = 1.75, p < .10). These results illustrate the importance of assessing plasma ΣLNAA when using the TRP depletion paradigm. The use of a single CSF sampling technique although practical may result in data acquisition limitations.
KW - Cerebrospinal fluid (CSF)
KW - Monoamine metabolites
KW - Neuropeptide Y
KW - Sum of large neutral amino acids (ΣLNAA)
KW - Tryptophan depletion
UR - http://www.scopus.com/inward/record.url?scp=71549120694&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=71549120694&partnerID=8YFLogxK
U2 - 10.1016/j.euroneuro.2009.10.003
DO - 10.1016/j.euroneuro.2009.10.003
M3 - Article
C2 - 19896342
AN - SCOPUS:71549120694
SN - 0924-977X
VL - 20
SP - 18
EP - 24
JO - European Neuropsychopharmacology
JF - European Neuropsychopharmacology
IS - 1
ER -